{"nct_id":"NCT01636713","title":"A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD","status":"COMPLETED","status_verified_date":"2016-11","start_date":"2012-07","start_date_type":null,"primary_completion_date":"2013-10","primary_completion_date_type":"ACTUAL","completion_date":"2013-10","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}